Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Healthcare, Pharmaceuticals & Biotechnology Healthcare and drugs Cancer Diagnostics: Early Detection of Breast, Prostate and Colorectal Cancer
Publications

(Currently 512486 Items)


Partners


Healthcare and drugs / REPORT INFORMATION

Cancer Diagnostics: Early Detection of Breast, Prostate and Colorectal Cancer

DateJan, 2001
Pages0
Price / format€1669 / Hard Copy
€1605 / Electronic
€1605 / Site License

€1 605 

Report Information | Custom-Tailored Research | Product Trade Lead


Abstract:
 The key to longer survival for patients is early detection of cancer through theuse of diagnostics. However their use as screening kits is severely limited bytheir shortcomings. The advent of DNA probes is bringing high expectationsof resolving these problems.








Table of contents:
 DATAMONITOR HEALTHCARE
CONTACT DETAILS
EXECUTIVE SUMMARY
INTRODUCTION
History of cancer diagnostics
Increase in incidence of cancer
CURRENT DIAGNOSTIC PRACTICE
Breast Cancer
Colorectal Cancer
Prostate Cancer
Cost of current diagnostic tests per patient
Main benefits and failures of current diagnostic practice
Key drivers of new diagnostic kits
Benefits to key players
Ideal characteristics of diagnostic kit
SWOT Analysis
Strengths of Current Diagnostic Practice
Weaknesses of Current Diagnostic Practice
Threats to Current Diagnostic Practice
Opportunities for Current Diagnostic Practice
Importance of early diagnosis
Key targets for diagnostic kits
Immunodetection (Tumor Markers)
Imaging Agents
Fecal Occult Blood Test (FOBT)
Genetic Testing
Key pipeline products
Breast Cancer
Colorectal Cancer
Prostate Cancer
Multiple Indications
SUMMARY AND CONCLUSION




Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found


Add New Buy/Sell Lead

© 2007-2010 MarketReportFinder.com